Study describes the use of restriction spectrum imaging as a biomarker that enhances the ability of MRI to differentiate aggressive cancer from benign tumors.
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
